<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - Syllabus B.Pharm. Semester _VIII</title><meta name="author" content="hp"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12.5pt; }
 h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; vertical-align: 7pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s6 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 14pt; }
 .s7 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s8 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 1pt; }
 .s9 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11pt; }
 .s10 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 .s11 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; }
 .s12 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 10.5pt; }
 .s13 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; vertical-align: 1pt; }
 .s14 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; }
 .s15 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 h4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 .s16 { color: #101010; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l1 {padding-left: 0pt; }
 #l1> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 139pt;text-indent: 0pt;text-align: left;">B.PHARM. SEMESTER- VIII</h2><h2 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">B.PHARM. SEMESTER- VIII</h2><h3 style="padding-top: 7pt;padding-left: 49pt;text-indent: 0pt;text-align: left;">PY 801 BIOSTATISITCS AND RESEARCH METHODOLOGY (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Scope: <span class="p">To understand the applications of Biostatics in Pharmacy. This subject deals with descriptive statistics, Graphics, Correlation, Regression, logistic regression Probability theory, Sampling technique, Parametric tests, Non Parametric tests, ANOVA, Introduction to Design of Experiments, Phases of Clinical trials and Observational and</span></h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 122%;text-align: justify;">Experimental studies, SPSS, R and MINITAB statistical software’s, analyzing the statistical data using Excel<b>.</b></p><h3 style="padding-top: 8pt;padding-left: 28pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Objectives: <span class="p">Upon completion of the course the student shall be able to</span></h3><p class="s1" style="text-indent: 0pt;line-height: 6pt;text-align: right;">®</p><p style="padding-left: 51pt;text-indent: -6pt;text-align: left;">Know the operation of M.S. Excel, SPSS, R and MINITAB , DoE (Design of Experiment)</p><p style="padding-left: 44pt;text-indent: 0pt;line-height: 114%;text-align: left;">Know the various statistical techniques to solve statistical problems Appreciate statistical techniques in solving the problems<b>.</b></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">Course content:</h3><h3 style="padding-top: 6pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-I</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Introduction: <span class="p">Statistics, Biostatistics, Frequency distribution</span></h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Measures of central tendency<span class="p">: Mean, Median, Mode- Pharmaceutical examples </span>Measures of dispersion<span class="p">: Dispersion, Range, standard deviation, Pharmaceutical problems</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Correlation<span class="p">: Definition, Karl Pearson’s coefficient of correlation, Multiple correlation</span></h3><p style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">- Pharmaceuticals examples</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-II</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 115%;text-align: left;">Regression: <span class="p">Curve fitting by the method of least squares, fitting the lines y= a + bx and x = a + by, Multiple regression, standard error of regression– Pharmaceutical Examples </span>Probability:<span class="p">Definition of probability, Binomial distribution, Normal distribution, Poisson’s distribution, properties - problems</span></h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Sample, Population, large sample, small sample, Null hypothesis, alternative hypothesis, sampling, essence of sampling, types of sampling, Error-I type, Error-II type, Standard error of mean (SEM) - Pharmaceutical examples</p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Parametric test<span class="p">: t-test(Sample, Pooled or Unpaired and Paired) , ANOVA, (One way and Two way), Least Significance difference</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-III</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Non Parametric tests: <span class="p">Wilcoxon Rank Sum Test, Mann-Whitney U test, Kruskal- Wallis test, Friedman Test</span></h3><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Introduction to Research: <span class="p">Need for research, Need for design of Experiments, Experiential Design Technique, plagiarism</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Graphs: <span class="p">Histogram, Pie Chart, Cubic Graph, response surface plot, Counter Plot graph </span>Designing the methodology: <span class="p">Sample size determination and Power of a study, Report writing and presentation of data, Protocol, Cohorts studies, Observational studies, Experimental studies, Designing clinical trial, various phases.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-IV</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Blocking and confounding system for Two-level factorials</p><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Regression modeling: <span class="p">Hypothesis testing in Simple and Multiple regressionmodels</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Introduction to Practical components of Industrial and Clinical Trials Problems<span class="p">:</span></h3><p class="s1" style="padding-left: 70pt;text-indent: 0pt;line-height: 6pt;text-align: center;">®</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Statistical Analysis Using Excel, SPSS, MINITAB , DESIGN OF EXPERIMENTS, R -</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Online Statistical Software’s to Industrial and Clinical trial approach</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-V</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Design and Analysis of experiments:</h3><p style="padding-left: 40pt;text-indent: 0pt;line-height: 20pt;text-align: left;"><b>Factorial Design: </b>Definition, 2<span class="s2">2</span>, 2<span class="s2">3</span>design. Advantage of factorial design</p><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Response Surface methodology<span class="p">: Central composite design, Historical design, Optimization Techniques</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest edition):</h3><p style="padding-top: 11pt;padding-left: 64pt;text-indent: 0pt;line-height: 110%;text-align: left;">Pharmaceutical statistics- Practical and clinical applications, Sanford Bolton, publisher Marcel Dekker Inc. NewYork.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Fundamental of Statistics – Himalaya Publishing House- S.C.Guptha</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;line-height: 122%;text-align: left;">Design and Analysis of Experiments –PHI Learning Private Limited, R. Pannerselvam,</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 11pt;text-align: left;">Design   and   Analysis    of Experiments –  Wiley Students Edition,</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Douglas and C. Montgomery</p><h3 style="padding-top: 3pt;padding-left: 105pt;text-indent: 0pt;text-align: left;">PY- 802 SOCIAL AND PREVENTIVE PHARMACY(Theory)</h3><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Scope:</h3><p style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">The purpose of this course is to introduce to students a number of health issues and their challenges. This course also introduced a number of national health programmes. The roles of the pharmacist in these contexts are also discussed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Objectives:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">After the successful completion of this course, the student shall be able to:</p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Acquire high consciousness/realization of current issuesrelated to health and pharmaceutical problems within the country and worldwide.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Have a critical way of thinking based on current healthcare development. Evaluate alternative ways of solving problems related tohealth and pharmaceutical issues</p><h3 style="padding-left: 56pt;text-indent: 0pt;line-height: 13pt;text-align: center;">Course content:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit I:</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Concept of health and disease: <span class="p">Definition, concepts and evaluation of public health. Understanding the concept of prevention and control of disease, social causes of diseases and social problems of the sick.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Social and health education: <span class="p">Food in relation to nutrition and health, Balanced diet, Nutritional deficiencies, Vitamin deficiencies, Malnutrition and its prevention.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Sociology and health: <span class="p">Socio cultural factors related to health and disease, Impact of urbanization on health and disease, Poverty and health</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Hygiene and health: <span class="p">personal hygiene and health care; avoidable habits</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit II:</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Preventive medicine: <span class="p">General principles of prevention and control of diseases such as cholera, SARS, Ebola virus, influenza, acute respiratory infections, malaria, chicken guinea, dengue, lymphatic filariasis, pneumonia, hypertension, diabetes mellitus, cancer, drug addiction-drug substance abuse</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit III:</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">National health programs, its objectives, functioning and outcome of the following: <span class="p">HIV AND AIDS control programme, TB, Integrated disease surveillance program (IDSP), National leprosy control programme, National mental health program, National</span></h3><p style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: justify;">programme for prevention and control of deafness, Universal immunization programme, National programme for control of blindness, Pulse polio programme.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit IV:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">National health intervention programme for mother and child, National family welfare programme, National tobacco control programme, National Malaria Prevention Program, National programme for the health care for the elderly, Social health programme; role of WHO in Indian national program</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit V:</h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Community services in rural, urban and school health: Functions of PHC, Improvement in rural sanitation, national urban health mission, Health promotion and education in school.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Recommended Books (Latest edition)<i>:</i></h3><p style="padding-top: 6pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Short Textbook of Preventive and Social Medicine, Prabhakara GN, 2<span class="s2">nd </span>Edition, 2010, ISBN: 9789380704104, JAYPEE Publications</p><p style="padding-top: 1pt;padding-left: 56pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Textbook of Preventive and Social Medicine (Mahajan and Gupta), Edited by Roy</p><p class="s1" style="padding-left: 2pt;text-indent: 0pt;line-height: 5pt;text-align: center;">th</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Rabindra Nath, Saha Indranil, 4 Edition, 2013, ISBN: 9789350901878, JAYPEE Publications</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 17pt;text-align: left;">Review of Preventive and Social Medicine (Including Biostatistics), Jain Vivek, 6<span class="s2">th</span></p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Edition, 2014, ISBN: 9789351522331, JAYPEE Publications</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Essentials of Community Medicine—A Practical Approach, Hiremath Lalita D, Hiremath Dhananjaya A, 2<span class="s2">nd </span>Edition, 2012, ISBN: 9789350250440, JAYPEE Publications</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 19pt;text-align: left;">Park Textbook of Preventive and Social Medicine, K Park, 21<span class="s2">st</span></p><p style="padding-top: 4pt;text-indent: 0pt;text-align: left;">Edition, 2011,</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">ISBN-14: 9788190128285, BANARSIDAS BHANOT PUBLISHERS.</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Community Pharmacy Practice, Ramesh Adepu, BSP publishers, Hyderabad</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Journals:</h3><p style="padding-top: 11pt;padding-left: 37pt;text-indent: 0pt;text-align: left;">1. <span class="s4">Research in Social and Administrative Pharmacy, Elsevier, Ireland</span></p><h3 style="padding-top: 3pt;padding-left: 94pt;text-indent: 0pt;text-align: left;">PY-803 A PHARMA MARKETING MANAGEMENT (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Scope:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">The pharmaceutical industry not only needs highly qualified researchers, chemists and, technical people, but also requires skilled managers who can take the industry forward by managing and taking the complex decisions which are imperative for the growth of the industry. The Knowledge and Know-how of marketing management groom the people for taking a challenging role in Sales and Product management.</p><h3 style="padding-top: 10pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Course Objective: <span class="p">The course aims to provide an understanding of marketing concepts and techniques and their applications in the pharmaceutical industry.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 31pt;text-indent: -3pt;line-height: 108%;text-align: left;">Unit I Marketing:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Definition, general concepts and scope of marketing; Distinction between marketing &amp; selling; Marketing environment; Industry and competitive analysis; Analyzing consumer buying behavior; industrial buying behavior.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Pharmaceutical market:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Quantitative and qualitative aspects; size and composition of the market; demographic descriptions  and  socio-psychological  characteristics  of  the  consumer;  market segmentation&amp; targeting.Consumer profile; Motivation and prescribing habits of the physician; patients&#39; choice of physician and retail pharmacist.Analyzing the Market;Role of market research.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit II</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Product decision:</h3><p style="padding-left: 22pt;text-indent: 2pt;line-height: 114%;text-align: left;">Classification, product line and product mix decisions, product life cycle,product portfolio analysis; product positioning; New product decisions; Product branding, packaging and labeling decisions, Product management in pharmaceutical industry.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 1pt;line-height: 117%;text-align: justify;">Unit III Promotion:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Methods, determinants of promotional mix, promotional budget; An overview of personal selling, advertising, direct mail, journals, sampling, retailing, medical exhibition, public relations, online promotional techniques for OTC Products.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit IV</h3><h3 style="padding-top: 1pt;padding-left: 31pt;text-indent: 0pt;text-align: justify;">Pharmaceutical marketing channels:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Designing channel, channel members, selecting the appropriate channel, conflict in channels, physical distribution management: Strategic importance, tasks in physical distribution management.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Professional sales representative (PSR):</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">Duties of PSR, purpose of detailing, selection and training, supervising, norms for customer calls, motivating, evaluating, compensation and future prospects of the PSR.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 108%;text-align: justify;">Unit V Pricing:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Meaning, importance, objectives, determinants of price; pricing methods and strategies, issues in price management in pharmaceutical industry. An overview of DPCO (Drug Price Control Order)and NPPA (National Pharmaceutical Pricing Authority).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Emerging concepts in marketing:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 108%;text-align: left;">Vertical &amp; Horizontal Marketing; RuralMarketing; Consumerism; Industrial Marketing; Global Marketing.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h3><p style="padding-top: 1pt;padding-left: 41pt;text-indent: 0pt;line-height: 110%;text-align: left;">Philip Kotler and Kevin Lane Keller: Marketing Management, Prentice Hall of India, New Delhi</p><p style="padding-top: 1pt;padding-left: 41pt;text-indent: 0pt;line-height: 111%;text-align: left;">Walker, Boyd and Larreche : Marketing Strategy- Planning and Implementation, Tata MC GrawHill, New Delhi.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Dhruv Grewal and Michael Levy: Marketing, Tata MC Graw Hill</p><p style="padding-top: 2pt;padding-left: 41pt;text-indent: 0pt;line-height: 114%;text-align: left;">Arun Kumar and N Menakshi: Marketing Management, Vikas Publishing, India Rajan Saxena: Marketing Management; Tata MC Graw-Hill (India Edition) Ramaswamy, U.S &amp; Nanakamari, S: Marketing Managemnt:Global Perspective, IndianContext,Macmilan India, New Delhi.</p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Shanker, Ravi: Service Marketing, Excell Books, New Delhi</p><p style="padding-top: 1pt;padding-left: 41pt;text-indent: 0pt;line-height: 125%;text-align: left;">Subba Rao Changanti, Pharmaceutical Marketing in India (GIFT – Excel series) Excel Publications.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">PY-803 B QUALITY CONTROL AND STANDARDIZATION OF HERBALS</h3><h3 style="padding-top: 2pt;padding-left: 46pt;text-indent: 0pt;text-align: center;">(Theory)</h3><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;line-height: 150%;text-align: left;">Scope: <span class="p">In this subject the student learns about the various methods and guidelines for evaluation and standardization of herbs and herbal drugs. The subject also provides an opportunity for the student to learn cGMP, GAP and GLP in traditional system of medicines.</span></h3><h3 style="padding-top: 5pt;padding-left: 64pt;text-indent: -36pt;line-height: 144%;text-align: left;">Objectives: <span class="p">Upon completion of the subject student shall be able to; know WHO guidelines for quality control of herbal drugs know Quality assurance in herbal drug industry</span></h3><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">know the regulatory approval process and their registration in Indian and international markets</p><p style="padding-top: 5pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">appreciate EU and ICH guidelines for quality control of herbal drugs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit I</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 120%;text-align: left;">Basic tests for drugs – Pharmaceutical substances, Medicinal plants materials and dosage forms</p><p class="s5" style="padding-left: 28pt;text-indent: 0pt;line-height: 122%;text-align: left;">WHO guidelines for quality control of herbal drugs. Evaluation of commercial crude drugs intended for use</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit II</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Quality assurance in herbal drug industry <span class="p">of cGMP, GAP, GMP and GLP in traditional system of medicine.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">WHO Guidelines on current good manufacturing Practices (cGMP) for Herbal Medicines WHO Guidelines on GACP for Medicinal Plants.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">EU and ICH guidelines for quality control of herbal drugs.</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit IV</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">Stability testing of herbal medicines.Application of various chromatographic techniques in standardization of herbal products.</p><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">Preparation of documents for new drug application and export registration GMP requirements and Drugs &amp; Cosmetics Act provisions.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit V</h3><p style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Regulatory requirements for herbal medicines.</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems Comparison of various Herbal Pharmacopoeias.</p><p style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Role of chemical and biological markers in standardization of herbal products</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 59pt;text-indent: -31pt;line-height: 111%;text-align: left;">Recommended Books: (Latest Editions <span class="p">Pharmacognosy by Trease and Evans Pharmacognosy by Kokate, Purohit and Gokhale</span></h3><p style="padding-top: 1pt;padding-left: 59pt;text-indent: 0pt;line-height: 111%;text-align: left;">Rangari, V.D., Text book of Pharmacognosy and Phytochemistry Vol. I , Carrier Pub., 2006.</p><p style="padding-left: 59pt;text-indent: 0pt;line-height: 114%;text-align: left;">Aggrawal, S.S., Herbal Drug Technology. Universities Press, 2002. EMEA. Guidelines on Quality of Herbal Medicinal Products/Traditional Medicinal Products,</p><p style="padding-left: 59pt;text-indent: 0pt;line-height: 110%;text-align: left;">Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. Business Horizons Publishers, New Delhi, India, 2002.</p><p class="s5" style="padding-top: 1pt;padding-left: 59pt;text-indent: 0pt;line-height: 115%;text-align: left;">Shinde M.V., Dhalwal K., Potdar K., Mahadik K. Application of quality control principles to herbal drugs. International Journal of Phytomedicine 1(2009); p. 4-8. <span class="s6">WHO. Quality Control Methods for Medicinal Plant Materials, World Health Organization, Geneva, 1998. WHO. Guidelines for the Appropriate Use of Herbal Medicines. WHO Regional Publications, Western Pacific Series No 3, WHO Regional office for the Western Pacific, Manila, 1998.</span></p><p style="padding-left: 59pt;text-indent: 0pt;line-height: 111%;text-align: left;">WHO. The International Pharmacopeia, Vol. 2: Quality Specifications, 3rd edn. World Health Organization, Geneva, 1981.</p><p style="padding-top: 1pt;padding-left: 59pt;text-indent: 0pt;line-height: 111%;text-align: left;">WHO. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva, 1999.</p><p style="padding-top: 1pt;padding-left: 59pt;text-indent: 0pt;line-height: 112%;text-align: left;">WHO. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. 2 vol. set. Vol. 1 contains text and Vol. 2, maps. World Health Organization, Geneva, 2005.</p><p style="padding-top: 1pt;padding-left: 59pt;text-indent: 0pt;line-height: 112%;text-align: left;">WHO. Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. World Health Organization, Geneva, 2004.</p><h1 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">PY-803 C COSMETIC SCIENCE <span class="s7">(Theory)</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT I</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Classification of cosmetic and cosmeceutical products</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Definition of cosmetics as per Indian and EU regulations, Evolution of cosmeceuticals from cosmetics, cosmetics as quasi and OTC drugs</p><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Cosmetic excipients: <span class="p">Surfactants, rheology modifiers, humectants, emollients, preservatives. Classification and application </span>Skin: <span class="p">Basic structure and function of skin.</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Hair: <span class="p">Basic structure of hair. Hair growth cycle.</span></h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Oral Cavity: <span class="p">Common problem associated with teeth and gums</span>.</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT II</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Principles of formulation and building blocks of skin care products:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Face wash,</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 120%;text-align: justify;">Moisturizing cream, Cold Cream, Vanishing cream and their advantages and disadvantages.Application of these products in formulation of cosmecuticals. <b>Antiperspants &amp; deodorants</b>- Actives &amp; mechanism of action.</p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Principles of formulation and building blocks of Hair care products:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Conditioning shampoo, Hair conditioner,anti-dandruff shampoo. Hair oils.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Chemistry and formulation of Para-phylene diamine based hair dye. Principles of formulation and building blocks of oral care products: Toothpaste for bleeding gums, sensitive teeth. Teeth whitening, Mouthwash.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT III</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Sun protection, Classification of Sunscreens and SPF.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Role of herbs in cosmetics:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Skin Care: Aloe and turmeric Hair care: Henna and amla.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Oral care: Neem and clove</p><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Analytical cosmetics: <span class="p">BIS specification and analytical methods for shampoo, skin- cream and toothpaste</span>.</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT IV</h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">Principles of Cosmetic Evaluation:Principles of sebumeter, corneometer. Measurement of TEWL, Skin Color, Hair tensile strength, Hair combing properties</p><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Soaps,and syndet bars. Evolution and skin benfits.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT V</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">Oily and dry skin, causes leading to dry skin, skin moisturisation. Basic understanding of the terms Comedogenic, dermatitis.</p><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Cosmetic problems associated with Hair and scalp: Dandruff, Hair fall causes Cosmetic problems associated with skin: blemishes, wrinkles, acne, prickly heat and body odor.</p><p style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Antiperspirants and Deodorants- Actives and mechanism of action</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">References</h3><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Harry’s Cosmeticology, Wilkinson, Moore, Seventh Edition, George Godwin. Cosmetics – Formulations, Manufacturing and Quality Control, P.P. Sharma, 4<span class="s2">th </span>Edition, Vandana Publications Pvt. Ltd., Delhi.</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Text book of cosmelicology by Sanju Nanda &amp; Roop K. Khar, Tata Publishers.</p><h3 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">PY-803 D PHARMACOLOGICAL SCREENING METHODS</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Scope:<span class="p">This subject is designed to impart the basic knowledge of preclinical studies in experimental animals including design, conduct and interpretations of results.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Upon completion of the course the student shall be able to,</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Appreciate the applications of various commonly used laboratory animals.</p><p style="padding-top: 3pt;padding-left: 63pt;text-indent: 0pt;line-height: 92%;text-align: left;">Appreciate <span class="s4">and demonstrate </span>the various screening methods used in <span class="s4">preclinical research</span></p><p style="padding-left: 63pt;text-indent: 0pt;text-align: left;">Appreciate <span class="s4">and demonstrate the importance of biostatistics and research</span>methodology Design and execute a research hypothesis independently</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_001.png"/></span>	<span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_002.png"/></span>	<span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_003.png"/></span></p><h3 style="padding-bottom: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit –I</h3><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_004.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_005.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_006.png"/></span></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Laboratory Animals:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Study of CPCSEA and OECD guidelines for maintenance, breeding and conduct of experiments on laboratory animals, Common lab animals: Description and applications of different species and strains of animals. Popular transgenic and mutant animals.</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Techniques for collection of blood and common routes of drug administration in laboratory animals, Techniques of blood collection and euthanasia.</p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_007.png"/></span>	<span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_008.png"/></span>	<span><img width="1" height="0" alt="image" src="syllabus060718034023-f526ae8c_files/Image_009.png"/></span></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit –II</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_010.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_011.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_012.png"/></span></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Preclinical screening models</h3><p style="padding-top: 2pt;padding-left: 46pt;text-indent: -18pt;line-height: 112%;text-align: justify;">a. Introduction: Dose selection, calculation and conversions, preparation of drug solution/suspensions, grouping of animals and importance of sham negative and positive control groups. Rationale for selection of animal species and sex for the study.</p><h3 style="padding-top: 1pt;padding-left: 46pt;text-indent: 0pt;text-align: left;">Study of screening animal models for</h3><p style="padding-left: 28pt;text-indent: 18pt;line-height: 118%;text-align: left;">Diuretics, nootropics, anti-Parkinson’s,antiasthmatics, <b>Preclinical screening models: </b>for CNS activity- analgesic, antipyretic,anti-inflammatory, general anaesthetics, sedative and hypnotics, antipsychotic, antidepressant, antiepileptic, antiparkinsonism, alzheimer’s disease</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_013.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_014.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_015.png"/></span></p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_016.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_017.png"/></span>	<span><img width="1" height="1" alt="image" src="syllabus060718034023-f526ae8c_files/Image_018.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit –III</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Preclinical screening models: <span class="p">for ANS activity, sympathomimetics, sympatholytics, parasympathomimetics, parasympatholytics, skeletal muscle relaxants, drugs acting on eye, local anaethetics</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit –IV</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Preclinical screening models: <span class="p">for CVS activity- antihypertensives, diuretics, antiarrhythmic, antidyslepidemic, anti aggregatory, coagulants, and anticoagulants</span></h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Preclinical screening models for other important drugs like antiulcer, antidiabetic, anticancer and antiasthmatics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Research methodology and Bio-statistics</h3><p style="padding-left: 41pt;text-indent: 0pt;line-height: 114%;text-align: left;">Selection of research topic, review of literature, research hypothesis and study design</p><p style="padding-top: 1pt;padding-left: 41pt;text-indent: 0pt;line-height: 108%;text-align: left;">Pre-clinical data analysis and interpretation using Students ‘t’ test and One-way ANOVA. Graphical representation of data</p><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (latest edition):</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 64pt;text-indent: 0pt;line-height: 115%;text-align: left;">Fundamentals of experimental Pharmacology-by M.N.Ghosh Hand book of Experimental Pharmacology-S.K.Kulakarni CPCSEA guidelines for laboratory animal facility.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Drug discovery and Evaluation by Vogel H.G.</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;line-height: 117%;text-align: left;">Drug Screening Methods by Suresh Kumar Gupta and S. K. Gupta Introduction to biostatistics and research methods by PSS Sundar Rao and J Richard</p><h3 style="padding-top: 3pt;padding-left: 37pt;text-indent: 0pt;text-align: left;">PY- 803 E ADVANCED INSTRUMENTATION TECHNIQUES (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Scope: <span class="p">This subject deals with the application of instrumental methods in qualitative and quantitative analysis of drugs. This subject is designed to impart advanced knowledge on the principles and instrumentation of spectroscopic and chromatographic hyphenated techniques. This also emphasizes on theoretical and practical knowledge on modern analytical instruments that are used for drug testing.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completion of the course the student shall be able to</span></h3><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">understand the advanced instruments used and its applications in drug analysis understand the chromatographic separation and analysis of drugs.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">understand the calibration of various analytical instruments know analysis of drugs using various analytical instruments.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 56pt;text-indent: 0pt;line-height: 14pt;text-align: center;">Course Content:</h3><h3 style="padding-left: 23pt;text-indent: 0pt;line-height: 14pt;text-align: left;">UNIT-I</h3><h3 style="padding-top: 2pt;padding-left: 23pt;text-indent: 0pt;text-align: justify;">Nuclear Magnetic Resonance spectroscopy</h3><p style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 111%;text-align: justify;">Principles of H-NMR and C-NMR, chemical shift, factors affecting chemical shift, coupling constant, Spin - spin coupling, relaxation, instrumentation and applications</p><h3 style="padding-left: 23pt;text-indent: 0pt;line-height: 117%;text-align: justify;">Mass Spectrometry<span class="p">- Principles, Fragmentation, Ionization techniques – Electron impact, chemical ionization,  MALDI, FAB, Analyzers-Time of flight and Quadrupole, instrumentation, applications</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-II</h3><h3 style="padding-top: 1pt;padding-left: 26pt;text-indent: -1pt;line-height: 113%;text-align: justify;">Thermal Methods of Analysis<span class="p">: Principles, instrumentation and applications of ThermogravimetricAnalysis (TGA), Differential Thermal Analysis (DTA), Differential Scanning Calorimetry (DSC)</span></h3><h3 style="padding-left: 59pt;text-indent: -35pt;line-height: 114%;text-align: justify;">X-Ray Diffraction Methods: <span class="p">Origin of X-rays, basic aspects of crystals, X- ray</span></h3><p style="padding-left: 23pt;text-indent: 3pt;line-height: 110%;text-align: justify;">Crystallography, rotating crystal technique, single crystal diffraction,powder diffraction, structural elucidation and applications.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-III</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 122%;text-align: left;">Calibration and validation-<span class="p">as per ICH and USFDA guidelines </span>Calibration of following Instruments</h3><p style="padding-left: 23pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Electronic balance, UV-Visible spectrophotometer, IR <span class="s4">spectrophotometer,</span></p><p style="padding-top: 3pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">Fluorimeter, Flame Photometer, HPLC and GC</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-IV</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 112%;text-align: left;">Radio immune assay:<span class="p">Importance, various components, Principle, different methods, Limitation and Applications of Radio immuno assay</span></h3><h3 style="padding-left: 23pt;text-indent: 0pt;line-height: 114%;text-align: left;">Extraction techniques<span class="p">:General principle and procedure involved in the solid phase extraction and liquid-liquid extraction</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-V</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">Hyphenated techniques<span class="p">-LC-MS/MS, GC-MS/MS, HPTLC-MS.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h3><p style="padding-top: 1pt;padding-left: 51pt;text-indent: 0pt;line-height: 114%;text-align: left;">Instrumental Methods of Chemical Analysis by B.K Sharma Organic spectroscopy by Y.R Sharma</p><p style="padding-left: 51pt;text-indent: -13pt;line-height: 114%;text-align: left;">3. Text book of Pharmaceutical Analysis by Kenneth A. Connors Vogel’s Text book of Quantitative Chemical Analysis by A.I. Vogel Practical Pharmaceutical Chemistry by A.H. Beckett and J.B. Stenlake Organic Chemistry by I. L. Finar</p><p style="padding-left: 51pt;text-indent: 0pt;line-height: 114%;text-align: left;">Organic spectroscopy by William Kemp Quantitative Analysis of Drugs by D. C. Garrett</p><p style="padding-left: 64pt;text-indent: -13pt;line-height: 117%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical Formulations by P. D. Sethi Spectrophotometric identification of Organic Compounds by Silver</p><h3 style="padding-top: 3pt;padding-left: 58pt;text-indent: 0pt;text-align: left;">PY-804 A: PHARMACEUTICAL REGULATORY SCIENCE (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Scope: <span class="p">This course is designed to impart the fundamental knowledge on the regulatory requirements for approval of new drugs, and drug products in regulated markets of India &amp; other countries like US, EU, Japan, Australia,UK etc. It prepares the students to learn in detail on the regulatory requirements, documentation requirements, and registration procedures for marketing the drug products.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 10pt;padding-left: 67pt;text-indent: -39pt;line-height: 144%;text-align: left;">Objectives: <span class="p">Upon completion of the subject student shall be able to; Know about the process of drug discovery and development</span></h3><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Know the regulatory authorities and agencies governing the manufacture and sale of pharmaceuticals</p><p style="padding-top: 6pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Know the regulatory approval process and their registration in Indian and international markets</p><h3 style="padding-top: 7pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">Course content:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit I</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">New Drug Discovery and development</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Stages of drug discovery, Drug development process, pre-clinical studies, non-clinical activities, clinical studies, Innovator and generics, Concept of generics, Generic drug product development.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit II</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Regulatory Approval Process</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Approval processes and timelines involved in Investigational New Drug (IND), New Drug Application (NDA), Abbreviated New Drug Application (ANDA). Changes to an approved NDA / ANDA.</p><h3 style="padding-top: 7pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Regulatory authorities and agencies</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: -1pt;text-align: left;">Overview of regulatory authorities of India, United States, European Union,   Australia, Japan, Canada (Organization structure and types of applications)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Registration of Indian drug product in overseas market</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Procedure for export of pharmaceutical products, Technical documentation, Drug Master Files (DMF), Common Technical Document (CTD), electronic Common Technical</p><p style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Document (eCTD), ASEAN Common Technical Document (ACTD)research.</p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 26pt;text-align: justify;">Unit IV Clinical trials</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Developing clinical trial protocols, Institutional Review Board / Independent Ethics committee - formation and working procedures, Informed consent process and procedures, GCP obligations of Investigators, sponsors &amp; Monitors, Managing and Monitoring clinical trials, Pharmacovigilance - safety monitoring in clinical trials</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit V</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 27pt;text-indent: 0pt;text-align: left;">Regulatory Concepts</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Basic terminology, guidance, guidelines, regulations, Laws and Acts, Orange book, Federal Register, Code of Federal Regulatory, Purple book</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended books (Latest edition):</h3><p style="padding-top: 4pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Drug Regulatory Affairs by Sachin Itkar, Dr. N.S. Vyawahare, Nirali Prakashan. The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R. Berry and Robert P. Martin, Drugs and the Pharmaceutical Sciences,Vol.185. Informa Health care Publishers.</p><p style="padding-left: 54pt;text-indent: 0pt;line-height: 12pt;text-align: left;">New Drug Approval Process: Accelerating Global Registrations By Richard</p><p class="s1" style="padding-left: 143pt;text-indent: 0pt;line-height: 5pt;text-align: left;">th</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 13pt;text-align: left;">A Guarino, MD, 5 edition, Drugs and the Pharmaceutical Sciences,Vol.190.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 92%;text-align: left;">Guidebook for drug regulatory submissions / Sandy Weinberg. By John Wiley &amp; Sons. Inc.</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">FDA Regulatory Affairs: a guide for prescription drugs, medical devices, and biologics /edited by Douglas J. Pisano, David Mantus.</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Generic Drug Product Development, Solid Oral Dosage forms, Leon Shargel and Isader Kaufer, Marcel Dekker series, Vol.143</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Clinical Trials and Human Research: A Practical Guide to Regulatory Compliance By Fay A. Rozovsky and Rodney K. Adams</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Principles and Practices of Clinical Research, Second Edition Edited by John I. Gallin and Frederick P. Ognibene</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Drugs: From Discovery to Approval, Second Edition By Rick</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 136pt;text-indent: 0pt;text-align: left;">PY- 804 B: PHARMACOVIGILANCE (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Scope: <span class="s10">This paper will provide an opportunity for the student to learn about development of pharmacovigilance as a science, basic terminologies used in pharmacovigilance, global scenario of Pharmacovigilance,  train  students  on  establishing  pharmacovigilance  programme  in  an organization, various methods that can be used to generate safety data and signal detection. This paper also develops the skills of classifying drugs, diseases and adverse drug reactions.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s11" style="padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">At completion of this paper it is expected that students will be able to (know, do, and appreciate):</p><p class="s10" style="padding-top: 10pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Why drug safety monitoring is important? History and development of pharmacovigilance</p><p class="s10" style="padding-left: 64pt;text-indent: 0pt;text-align: left;">National and international scenario of pharmacovigilance Dictionaries, coding and terminologies used in pharmacovigilance Detection of new adverse drug reactions and their assessment International standards for classification of diseases and drugs</p><p class="s10" style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Adverse drug reaction reporting systems and communication in pharmacovigilance Methods to generate safety data during pre clinical, clinical and post approval phases of drugs’ life cycle</p><p class="s10" style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Drug safety evaluation in paediatrics, geriatrics, pregnancy and lactation Pharmacovigilance Program of India (PvPI) requirement for ADR reporting in India ICH guidelines for ICSR, PSUR, expedited reporting, pharmacovigilance planning CIOMS requirements for ADR reporting</p><p class="s10" style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Writing case narratives of adverse events and their quality.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 56pt;text-indent: 0pt;text-align: center;">Course Content</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit I</p><p class="s9" style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Introduction to Pharmacovigilance</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">History and development of Pharmacovigilance Importance of safety monitoring of Medicine WHO international drug monitoring programme Pharmacovigilance Program of India(PvPI)</p><p class="s9" style="padding-left: 82pt;text-indent: -54pt;line-height: 111%;text-align: left;">Introduction to adverse drug reactions <span class="s10">Definitions and classification of ADRs Detection and reporting</span></p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">Methods in Causality assessment Severity and seriousness assessment</p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 113%;text-align: left;">Predictability and preventability assessment Management of adverse drug reactions</p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Basic terminologies used in pharmacovigilance</p><p class="s10" style="padding-top: 3pt;padding-left: 82pt;text-indent: 0pt;line-height: 110%;text-align: left;">Terminologies of adverse medication related events Regulatory terminologies</p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit II</p><p class="s9" style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Drug and disease classification</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">Anatomical, therapeutic and chemical classification of drugs International classification of diseases</p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Daily defined doses</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">International Non proprietary Names for drugs</p><p class="s9" style="padding-top: 2pt;padding-left: 82pt;text-indent: -54pt;line-height: 111%;text-align: left;">Drug dictionaries and coding in pharmacovigilance <span class="s10">WHO adverse reaction terminologies MedDRA and Standardised MedDRA queries WHO drug dictionary</span></p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;text-align: left;">Eudravigilance medicinal product dictionary</p><p class="s9" style="padding-top: 2pt;padding-left: 82pt;text-indent: -54pt;line-height: 111%;text-align: left;">Information resources in pharmacovigilance <span class="s10">Basic drug information resources Specialised resources for ADRs</span></p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Establishing pharmacovigilance programme</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Establishing in a hospital</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 113%;text-align: left;">Establishment &amp; operation of drug safety department in industry Contract Research Organisations (CROs)</p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Establishing a national programme</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit III</p><p class="s9" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Vaccine safety surveillance</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">Vaccine Pharmacovigilance Vaccination failure</p><p class="s10" style="padding-left: 82pt;text-indent: 0pt;text-align: left;">Adverse events following immunization</p><p class="s9" style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Pharmacovigilance methods</p><p class="s10" style="padding-top: 2pt;padding-left: 82pt;text-indent: 0pt;line-height: 106%;text-align: left;">Passive surveillance – Spontaneous reports and case series Stimulated reporting</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 108%;text-align: left;">Active surveillance – Sentinel sites, drug event monitoring and registries Comparative observational studies – Cross sectional study, case control study and cohort study</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Targeted clinical investigations</p><p class="s9" style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Communication in pharmacovigilance</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">Effective communication in Pharmacovigilance Communication in Drug Safety Crisis management</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 106%;text-align: left;">Communicating with Regulatory Agencies, Business Partners, Healthcare facilities &amp; Media</p><p class="s9" style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit IV</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Safety data generation</p><p class="s13" style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Pre clinical phase</span></p><p class="s13" style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s15">Clinical phase</span></p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Post approval phase (PMS)</span></p><p class="s9" style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">ICH Guidelines for Pharmacovigilance</p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Organization and objectives of ICH</span></p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Expedited reporting</span></p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Individual case safety reports</span></p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Periodic safety update reports</span></p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Post approval expedited reporting</span></p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s15">Pharmacovigilance planning</span></p><p class="s13" style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">1 <span class="s14">Good clinical practice in pharmacovigilance studie</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit V</p><p class="s9" style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Pharmacogenomics of adverse drug reactions</p><p class="s10" style="padding-top: 1pt;padding-left: 77pt;text-indent: 0pt;text-align: left;">Genetics related ADR with example focusing PK parameters.</p><p class="s9" style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Drug safety evaluation in special population</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Paediatrics</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 112%;text-align: left;">Pregnancy and lactation Geriatrics</p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">CIOMS</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 14pt;text-indent: 0pt;line-height: 113%;text-align: left;">CIOMS Working Groups CIOMS Form</p><p class="s9" style="padding-left: 28pt;text-indent: 0pt;text-align: left;">CDSCO (India) and Pharmacovigilance</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">D&amp;C Act and Schedule Y</p><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Differences in Indian and global pharmacovigilance requirements</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest edition):</h3><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Textbook of Pharmacovigilance: S K Gupta, Jaypee Brothers, Medical Publishers. Practical Drug Safety from A to Z By Barton Cobert, Pierre Biron, Jones and Bartlett Publishers.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Mann&#39;s Pharmacovigilance:Elizabeth B. Andrews, Nicholas, Wiley Publishers. Stephens&#39; Detection of New Adverse Drug Reactions: John Talbot, Patrick Walle, Wiley Publishers.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">An Introduction to Pharmacovigilance: Patrick Waller,Wiley Publishers. Cobert&#39;s Manual of Drug Safety and Pharmacovigilance: Barton Cobert,Jones&amp; Bartlett Publishers.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Textbook of Pharmacoepidemiolog edited by Brian L. Strom, Stephen E Kimmel, Sean Hennessy,Wiley Publishers.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">A Textbook of Clinical Pharmacy Practice -Essential Concepts and Skills:G. Parthasarathi, Karin NyfortHansen,Milap C. Nahata</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 14pt;text-align: left;">National Formulary of India</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Text Book of Medicine by Yashpal Munjal</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Text book of Pharmacovigilance: concept and practice by GP Mohanta and PK Manna</p><h3 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">PY- 804 C. COMPUTER AIDED DRUG DESIGN (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 118%;text-align: left;">Scope: <span class="p">This subject is designed to provide detailed knowledge of rational drug design process and various techniques used in rational drug design process.</span></h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives: <span class="p">Upon completion of the course, the student shall be able to understand</span></h3><p style="padding-top: 5pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Design and discovery of lead molecules</p><p style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 117%;text-align: left;">The role of drug design in drug discovery process The concept of QSAR and docking</p><p style="padding-left: 82pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Various strategies to develop new drug like molecules.</p><p style="padding-top: 2pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">The design of new drug molecules using molecular modeling software</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Course Content:</h3><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-I</h3><h4 style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Introduction to Drug Discovery and Development</h4><p class="s5" style="padding-top: 3pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Stages of drug discovery and development</p><h3 style="padding-top: 4pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Lead discovery and Analog Based Drug Design</h3><p style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: justify;">Rational approaches to lead discovery based on traditional medicine, Random screening, Non-random screening, serendipitous drug discovery, lead discovery based on drug metabolism, lead discovery based on clinical observation.</p><h3 style="padding-top: 3pt;padding-left: 51pt;text-indent: 0pt;text-align: justify;">Analog Based Drug Design:<span class="p">Bioisosterism, Classification, Bioisosteric replacement. Any three case studies</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-II</h3><h3 style="padding-top: 3pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Quantitative Structure Activity Relationship (QSAR)</h3><p style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">SAR versus QSAR, History and development of QSAR, Types of physicochemical parameters, experimental and theoretical approaches for the determination of    physicochemical parameters such as Partition coefficient, Hammet’s substituent constant and Tafts steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR approaches like COMFA and COMSIA.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-III</h3><h3 style="padding-top: 3pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Molecular Modeling and virtual screening techniques</h3><h3 style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Virtual Screening techniques: <span class="p">Drug likeness screening, Concept of pharmacophore mapping and pharmacophore based Screening,</span></h3><p style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: left;"><b>Molecular docking</b>: Rigid docking, flexible docking, manual docking, Docking based screening. <i>De novo </i>drug design.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-IV</h3><h3 style="padding-top: 3pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Informatics &amp; Methods in drug design</h3><p style="padding-top: 2pt;padding-left: 51pt;text-indent: 0pt;text-align: left;">Introduction to Bioinformatics, chemoinformatics. ADME databases, chemical, biochemical and pharmaceutical databases.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-V</h3><h3 style="padding-left: 51pt;text-indent: 0pt;text-align: justify;">Molecular Modeling: <span class="p">Introduction to molecular mechanics and quantum mechanics.Energy Minimization methods and Conformational Analysis, global conformational minima determination.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s5" style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Robert GCK, ed., “Drug Action at the Molecular Level” University Prak Press Baltimore.</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Martin YC. “Quantitative Drug Design” Dekker, New York.</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">Delgado JN, Remers WA eds “Wilson &amp; Gisvolds’s Text Book of Organic Medicinal &amp; Pharmaceutical Chemistry” Lippincott, New York.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Foye WO “Principles of Medicinal chemistry ‘Lea &amp; Febiger.</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">Koro lkovas A, Burckhalter JH. “Essentials of Medicinal Chemistry” Wiley Interscience.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 118%;text-align: left;">Wolf ME, ed “The Basis of Medicinal Chemistry, Burger’s Medicinal Chemistry” John Wiley &amp; Sons, New York.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 111%;text-align: left;">Patrick Graham, L., An Introduction to Medicinal Chemistry, Oxford University Press.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">Smith HJ, Williams H, eds, “Introduction to the principles of Drug Design” Wright Boston.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 123%;text-align: left;">Silverman R.B. “The organic Chemistry of Drug Design and Drug Action” Academic Press New York.</p><h3 style="padding-top: 3pt;padding-left: 68pt;text-indent: 0pt;text-align: justify;">PY-804 D : CELL AND MOLECULAR BIOLOGY (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Scope:</h3><ul id="l1"><li data-list-text=""><p style="padding-left: 64pt;text-indent: -18pt;line-height: 112%;text-align: justify;">Cell biology is a branch of biology that studies cells – their physiological properties, their structure, the organelles they contain, interactions with their environment, their life cycle, division, death and cell function.</p></li></ul><p style="padding-left: 64pt;text-indent: 0pt;text-align: justify;">This is done both on a microscopic and molecular level.</p><p style="padding-top: 3pt;padding-left: 64pt;text-indent: 0pt;line-height: 109%;text-align: justify;">Cell biology research encompasses both the great diversity of single-celled organisms like bacteria and protozoa, as well as the many specialized cells in multi-cellular organismssuch as humans, plants, and sponges.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 64pt;text-indent: -36pt;line-height: 117%;text-align: left;">Objectives: <span class="p">Upon completion of the subject student shall be able to; Summarize cell and molecular biology history.</span></h3><p style="padding-left: 64pt;text-indent: 0pt;line-height: 114%;text-align: left;">Summarize cellular functioning and composition. Describe the chemical foundations of cell biology. Summarize the DNA properties of cell biology.</p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Describe protein structure and function.</p><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;line-height: 117%;text-align: left;">Describe cellular membrane structure and function. Describe basic molecular genetic mechanisms.</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Summarize the Cell Cycle</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit I</h3><h3 style="padding-top: 2pt;padding-left: 6pt;text-indent: 0pt;text-align: center;">Course content:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 114%;text-align: left;">Cell and Molecular Biology: Definitions theory and basics and Applications. Cell and Molecular Biology: History and Summation.</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 115%;text-align: left;">Properties of cells and cell membrane. Prokaryotic versus Eukaryotic Cellular Reproduction</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Chemical Foundations – an Introduction and Reactions (Types)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit II</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 1pt;text-indent: -2pt;line-height: 127%;text-align: left;">DNA and the Flow of Molecular Information DNA Functioning</p><p style="text-indent: 0pt;line-height: 111%;text-align: left;">DNA and RNA Types of RNA</p><p style="text-indent: 0pt;text-align: left;">Transcription and Translation</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;line-height: 112%;text-align: left;">Proteins: Defined <b>and </b>Amino Acids Protein Structure</p><p style="padding-top: 3pt;padding-left: 64pt;text-indent: 0pt;line-height: 112%;text-align: left;">Regularities in Protein Pathways Cellular Processes</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Positive Control and significance of Protein Synthesis</p><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit IV</h3><p style="padding-top: 1pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Science of Genetics</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 3pt;line-height: 114%;text-align: left;">Transgenics and Genomic Analysis Cell Cycle analysis</p><p style="padding-left: 64pt;text-indent: 0pt;text-align: left;">Mitosis and Meiosis</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">Cellular Activities and Checkpoints</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit V</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;line-height: 114%;text-align: left;">Cell Signals: Introduction Receptors for Cell Signals Signaling Pathways: Overview</p><p style="text-indent: 0pt;line-height: 114%;text-align: left;">Misregulation of Signaling Pathways Protein-Kinases: Functioning</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (latest edition):</h3><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;line-height: 110%;text-align: left;">W.B. Hugo and A.D. Russel: Pharmaceutical Microbiology, Blackwell Scientific publications, Oxford London.</p><p style="padding-left: 54pt;text-indent: 0pt;line-height: 17pt;text-align: left;">Prescott and Dunn., Industrial Microbiology, 4<span class="s2">th </span>edition, CBS Publishers</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">&amp; Distributors, Delhi.</p><p style="padding-top: 2pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">Pelczar, Chan Kreig, Microbiology, Tata McGraw Hill edn.</p><p style="padding-top: 2pt;padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">Malcolm Harris, Balliere Tindall and Cox: Pharmaceutical Microbiology. Rose: Industrial Microbiology.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">Probisher, Hinsdill et al: Fundamentals of Microbiology, 9th ed. Japan Cooper and Gunn’s: Tutorial Pharmacy, CBS Publisher and Distribution. Peppler: Microbial Technology.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Edward: Fundamentals of Microbiology.</p><p style="padding-top: 2pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">N.K.Jain: Pharmaceutical Microbiology, Vallabh Prakashan, Delhi</p><p style="padding-top: 2pt;padding-left: 55pt;text-indent: 0pt;line-height: 111%;text-align: left;">Bergeys manual of systematic bacteriology, Williams and Wilkins- A Waverly company</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">B.R. Glick and J.J. Pasternak: Molecular Biotechnology: Principles and Applications of RecombinantDNA: ASM Press Washington D.C.</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">RA Goldshy et. al., : Kuby Immunology.</p><h4 style="padding-top: 3pt;padding-left: 49pt;text-indent: 0pt;text-align: left;">PY- 804 E. DIETARY SUPPLEMENTS AND NUTRACEUTICALS(Theory)</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Scope :</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 111%;text-align: left;">This subject covers foundational topic that are important for understanding the need and requirements of dietary supplements among different groups in the population.</p><h3 style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Objective:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 111%;text-align: left;">This module aims to provide an understanding of the concepts behind the theoretical applications of dietary supplements. By the end of the course, students should be able to :</p><p style="padding-top: 11pt;padding-left: 41pt;text-indent: 0pt;text-align: left;">Understand the need of supplements by the different group of people to maintain healthy life.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Understand the outcome of deficiencies in dietary supplements. Appreciate the components in dietary supplements and the application.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Appreciate the regulatory and commercial aspects of dietary supplements including health claims.</p><h3 style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT I</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Definitions of Functional foods, Nutraceuticals and Dietary supplements. Classification of Nutraceuticals, Health problems and diseases that can be prevented or cured by Nutraceuticals i.e. weight control, diabetes, cancer, heart disease, stress, osteoarthritis, hypertension etc.</p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 110%;text-align: justify;">Public health nutrition, maternal and child nutrition, nutrition and ageing, nutrition education in community.</p><p style="padding-top: 1pt;padding-left: 43pt;text-indent: 0pt;text-align: justify;">Source, Name of marker compounds and their chemical nature, Medicinal uses and</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 111%;text-align: left;">health benefits of following used as nutraceuticals/functional foods: Spirulina, Soyabean, Ginseng, Garlic, Broccoli, Gingko, Flaxseeds</p><h4 style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT II</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 111%;text-align: left;">Phytochemicals as nutraceuticals: Occurrence and characteristic features(chemical nature medicinal benefits) of following</p><p style="padding-top: 9pt;padding-left: 41pt;text-indent: 0pt;line-height: 108%;text-align: left;">Carotenoids- α and β-Carotene, Lycopene, Xanthophylls, leutin Sulfides: Diallyl sulfides, Allyl trisulfide.</p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Polyphenolics: Reservetrol</p><p style="padding-top: 2pt;padding-left: 41pt;text-indent: 0pt;line-height: 114%;text-align: left;">Flavonoids- Rutin , Naringin, Quercitin, Anthocyanidins, catechins, Flavones Prebiotics / Probiotics.: Fructo oligosaccharides, Lacto bacillum</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Phyto estrogens : Isoflavones, daidzein, Geebustin, lignans Tocopherols</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Proteins, vitamins, minerals, cereal, vegetables and beverages as functional foods: oats, wheat bran, rice bran, sea foods, coffee, tea and the like.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT III</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 41pt;text-indent: 0pt;text-align: justify;">Introduction to free radicals: Free radicals, reactive oxygen species, production of free radicals in cells, damaging reactions of free radicals on lipids, proteins, Carbohydrates, nucleic acids.</p><p style="padding-top: 3pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">b) <span class="s4">Dietary fibres and complex carbohydrates as functional food ingredients..</span></p><h3 style="padding-left: 9pt;text-indent: 0pt;text-align: left;">UNIT IV</h3><p style="padding-top: 11pt;padding-left: 41pt;text-indent: 0pt;text-align: left;">Free radicals in Diabetes mellitus, Inflammation, Ischemic reperfusion injury, Cancer, Atherosclerosis, Free radicals in brain metabolism and pathology, kidney damage, muscle damage. Free radicals involvement in other disorders. Free radicals theory of ageing.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: justify;">Antioxidants: Endogenous antioxidants – enzymatic and nonenzymatic antioxidant defence, Superoxide dismutase, catalase, Glutathione peroxidase, Glutathione Vitamin C, Vitamin E, α- Lipoic acid, melatonin</p><p style="padding-left: 45pt;text-indent: -3pt;text-align: justify;">Synthetic antioxidants: Butylated hydroxy Toluene, Butylated hydroxy Anisole. Functional foods for chronic disease prevention</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 9pt;text-indent: 0pt;text-align: left;">UNIT V</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 4pt;line-height: 111%;text-align: left;">Effect of processing, storage and interactions of various environmental factors on the potential of nutraceuticals.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 4pt;text-align: left;">Regulatory Aspects; FSSAI, FDA, FPO, MPO, AGMARK. HACCP and GMPs on Food Safety. Adulteration of foods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 10pt;text-indent: 0pt;text-align: left;">Pharmacopoeial Specifications for dietary supplements and nutraceuticals.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">References:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Dietetics by Sri Lakshmi</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Role of dietary fibres and neutraceuticals in preventing diseases by K.T Agusti and P.Faizal: BSPunblication.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: left;">Advanced Nutritional Therapies by Cooper. K.A., (1996).</p><p style="padding-top: 3pt;padding-left: 41pt;text-indent: 0pt;line-height: 75%;text-align: left;">The Food Pharmacy by Jean Carper, Simon &amp; Schuster, UK Ltd., (1988). Prescription for Nutritional Healing by James F.Balch and Phyllis A.Balch 2<span class="s2">nd</span></p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Avery Publishing Group, NY (1997).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 4pt;text-indent: 0pt;text-align: left;">Edn.,</p><p style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">6. G. Gibson and C.williams Editors <i>2000 Functional foods </i>Woodhead <span class="s4">Publ.Co.London.</span></p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Goldberg, I. <i>Functional Foods</i>. 1994. Chapman and Hall, New York.</p><p style="padding-left: 41pt;text-indent: 0pt;text-align: justify;">Labuza, T.P. 2000 Functional Foods and Dietary Supplements: Safety, Good Manufacturing Practice (GMPs) and Shelf Life Testing in <i>Essentials of Functional Foods </i>M.K. Sachmidl and T.P. Labuza eds. Aspen Press.</p><p class="s16" style="padding-left: 41pt;text-indent: 0pt;text-align: justify;">Handbook of Nutraceuticals and Functional Foods, Third Edition (Modern Nutrition)</p><p style="padding-top: 5pt;padding-left: 41pt;text-indent: 0pt;text-align: justify;">Shils, ME, Olson, JA, Shike, M. 1994 <i>Modern Nutrition in Health and Disease</i>. Eighth edition. Lea and Febiger</p><h4 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: center;">PY-804 F PHARMACEUTICAL PRODUCT DEVELOPMENT (Theory)</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-I</h4><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: justify;">Introduction to pharmaceutical product development, objectives, regulations related to preformulation, formulation development, stability assessment, manufacturing and quality control testing of different types of dosage forms</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-II</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">An advanced study of Pharmaceutical Excipients in pharmaceutical product development with a special reference to the following categories</p><p style="padding-left: 100pt;text-indent: 0pt;line-height: 114%;text-align: left;">Solvents and solubilizers Cyclodextrins and their applications</p><p style="padding-left: 100pt;text-indent: 0pt;line-height: 115%;text-align: left;">Non - ionic surfactants and their applications Polyethylene glycols and sorbitols Suspending and emulsifying agents</p><p style="padding-left: 100pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Semi solid excipients</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-III</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">An advanced study of Pharmaceutical Excipients in pharmaceutical product development with a special reference to the following categories</p><p style="padding-left: 100pt;text-indent: 0pt;line-height: 114%;text-align: left;">Tablet and capsule excipients Directly compressible vehicles Coat materials</p><p style="padding-left: 100pt;text-indent: 0pt;line-height: 112%;text-align: left;">Excipients in parenteral and aerosols products Excipients for formulation of NDDS</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">Selection and application of excipients in pharmaceutical formulations with specific industrial applications</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-IV</h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Optimization techniques in pharmaceutical product development.A study of various optimization  techniques  for  pharmaceutical  product  development  with  specific examples.Optimization by factorial designs and their applications.A study of QbD and its application in pharmaceutical product development.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-V</h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">Selection and quality control testing of packaging materials for pharmaceutical product development- regulatory considerations.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest editions)</h3><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;line-height: 111%;text-align: left;">Pharmaceutical Statistics Practical and Clinical Applications by Stanford Bolton, CharlesBon; Marcel Dekker Inc.</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;line-height: 111%;text-align: left;">Encyclopedia of Pharmaceutical Technology, edited by James swarbrick, Third Edition,Informa Healthcare publishers.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 111%;text-align: left;">Pharmaceutical Dosage Forms, Tablets, Volume II, edited by Herbert A. Lieberman andLeon Lachman; Marcel Dekker, Inc.</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;line-height: 111%;text-align: left;">The Theory and Practice of Industrial Pharmacy, Fourth Edition, edited by Roop kKhar, S P Vyas, Farhan J Ahmad, Gaurav K Jain; CBS Publishers and Distributors Pvt.Ltd. 2013.</p><p style="padding-left: 64pt;text-indent: -9pt;line-height: 120%;text-align: left;">Martin’s Physical Pharmacy and Pharmaceutical Sciences, Fifth Edition, edited by Patrick J. Sinko, BI Publications Pvt. Ltd.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Targeted and Controlled Drug Delivery, Novel Carrier Systems by S. P. Vyas and R. K.Khar, CBS Publishers and Distributors Pvt. Ltd, First Edition 2012. Pharmaceutical Dosage Forms and Drug Delivery Systems, Loyd V. Allen Jr., Nicholas B.Popovich, Howard C. Ansel, 9th Ed. 40</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">Aulton’s Pharmaceutics – The Design and Manufacture of Medicines, Michael E. Aulton,3rd Ed.</p><p style="padding-left: 55pt;text-indent: 0pt;text-align: left;">Remington – The Science and Practice of Pharmacy, 20th Ed.</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">Pharmaceutical Dosage Forms – Tablets Vol 1 to 3, A. Liberman, Leon Lachman andJoseph B. Schwartz</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 114%;text-align: left;">Pharmaceutical Dosage Forms – Disperse Systems Vol 1 to 3, H.A. Liberman, Martin, M.R and Gilbert S. Banker.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 120%;text-align: left;">Pharmaceutical Dosage Forms – Parenteral Medication Vol 1 &amp; 2, Kenneth E. Avis andH.A. Libermann.</p><p style="padding-left: 55pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Advanced Review Articles related to the topics.</p><h3 style="padding-top: 3pt;padding-left: 100pt;text-indent: 0pt;text-align: left;">PY-805 PRACTICE SCHOOL (Practical)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Every candidate shall undergo practice school for a period of 150 hours evenly distributed throughout the semester. The student shall opt any one of the domains for practice school .</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">At the end of the practice school, every student shall submit a printed report (in triplicate) on the practice school he/she attended (not more than 25 pages). Along with the exams of semester VII, the report submitted by the student, knowledge and skills acquired by the student through practice school shall be evaluated by the subject experts at college level and grade point shall be awarded.</p></body></html>
